Adaptive Biotechnologies vs Cradle

Adaptive Biotechnologies vs Cradle, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Cradle on 69/100.

Adaptive Biotechnologies logo
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.
Try Adaptive Biotechnologies
Cradle logo
CradleCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Try Cradle

Where each one leads

Adaptive Biotechnologies

  • domain rating: 61/100 against 53/100
  • funding raised: $300M against $102M

Cradle

  • agent readiness: 44/100 against 39/100

At a glance

MeasureAdaptive BiotechnologiesCradle
What it isLeveraging the adaptive immune system to diagnose and treat disease.Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
CategoryBiotech, HealthTech, Genomics, Drug DiscoveryBiotech, HealthTech, AI-Driven Protein Design, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingSoftware | services | platformSoftware | platform
Founded20092021
HeadquartersSeattle, United StatesAmsterdam, Netherlands
StatusActiveActive

Size, funding and growth

MeasureAdaptive BiotechnologiesCradle
EmployeesNot published112
Total funding$300M$102M
Latest roundSeries DSeries B
LinkedIn followersNot published27,926

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdaptive BiotechnologiesCradle
StartupHub scoreOur 0-100 rating69/10069/100
TractionNot published60/100
TeamNot published70/100
CommunityNot published17/100
Search visibilityNot published56/100
QualityNot published78/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (44/100)
Domain ratingLink authority, 0-10061/10053/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdaptive BiotechnologiesCradle
HostingSelf ManagedNot detected
CMSWordPressFramer
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerNot detected

Adaptive Biotechnologies vs Cradle: common questions

Which is better, Adaptive Biotechnologies or Cradle?

Both score the same on our 0-100 rating, so the choice comes down to the 13 data points in the tables above rather than overall company strength.

How do Adaptive Biotechnologies and Cradle compare on the numbers?

Adaptive Biotechnologies leads on domain rating (61/100 against 53/100), funding raised ($300M against $102M). Cradle leads on agent readiness (44/100 against 39/100).

Read the full Adaptive Biotechnologies review and pricing or the Cradle review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.